Clinical Trial Update: Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a lower-dose decitabine-based therapy for patients with refractory or chemotherapy-resistant solid tumors and B-cell lymphoma, spanning…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Solid Tumors

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: Han weidong | Conditions: Solid Tumors, B Cell Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN